US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

Claravis

Reason Failed Impurities/Degradation Specifications.

Teva North America NDC 00555-1054-86 D-0005-2017
Class III · Low risk Terminated

Mozobil

Reason Labeling: Incorrect or Missing Lot and/or Exp. Date

Genzyme Corporation / Genzyme Biosurgery NDC 0024-5862-01 D-1518-2016
Class III · Low risk Terminated

buPROPion Hydrochloride Extended-Release Tablets

Reason Failed dissolution specifications - the out of specification result for dissolution was identified during 3 month stability testing.

Amerisource Health Services NDC 68001-264-03 D-1501-2016
Class III · Low risk Terminated

Mucinex Sinus-Max Day Night

Reason Labeling: Label Error on Declared Strength; label on outer carton incorrectly states Diphenhydramine 25 mg instead of 12.5 mg. Also, quantity is incorrectly stated as 30 daytime and 30 nighttime instead of 36 daytime and 24 nighttime.

Reckitt Benckiser LLC NDC 63824-207-60 D-1517-2016
Class III · Low risk Terminated

BuPROPion Hydrochloride Extended-Release Tablets

Reason Failed Dissolution Specifications: Product did not meet dissolution specification at an intermediate time point.

Zydus Pharmaceuticals USA Inc NDC 68382-354-05 D-0149-2017
Class III · Low risk Terminated

Hydrocortisone and acetic acid otic solution

Reason Failed Impurities/Degradation Specifications: Out of specification (OOS) results for related compound G were obtained at 12-month (at expiry) stability time-point for room temperature sample(s).

Actavis Inc NDC 45963-412-61 D-1472-2016
Class III · Low risk Terminated

Acetasol HC

Reason Failed Impurities/Degradation Specifications: Out of specification (OOS) results for related compound G were obtained at 12-month (at expiry) stability time-point for room temperature sample(s).

Actavis Inc NDC 0472-0882-82 D-1471-2016
Class III · Low risk Terminated

Desoximetasone Gel USP

Reason Failed impurities/degradation specifications: product was out of specification for unknown impurity at the 9 month stability time point

Akorn, Inc. NDC 61748-205-60 D-1469-2016
Class III · Low risk Terminated

Children's Qnasl 40 mcg

Reason Failed Content Uniformity Specifications: out of specification test result for spray content uniformity.

Teva North America NDC 59310-206-08 D-1453-2016
Class III · Low risk Terminated

5% Lidocaine HCL and 7.5% Dextrose Injection

Reason Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.

Hospira Inc. NDC 0409-4712-01 D-0169-2017
Class III · Low risk Terminated

DULOXETINE Delayed-Release Capsules

Reason Labeling; Incorrect or Missing Lot and/or Exp Date; incorrect expiration date on container label is 02/2019, correct expiration date should be 02/2018

Golden State Medical Supply Inc. NDC 60429-166-10 D-1255-2016
Class III · Low risk Terminated

Carvediol Tablets

Reason Failed Impurities/Degradation Specifications

Sun Pharmaceutical Industries, Inc. NDC 57664-247-88 D-1507-2016
Class III · Low risk Terminated

Carvediol Tablets

Reason Failed Impurities/Degradation Specifications

Sun Pharmaceutical Industries, Inc. NDC 57664-245-13 D-1506-2016
Class III · Low risk Terminated

Carvediol Tablets

Reason Failed Impurities/Degradation Specifications

Sun Pharmaceutical Industries, Inc. NDC 57664-244-18 D-1505-2016
Class III · Low risk Terminated

Carvediol Tablets

Reason Failed Impurities/Degradation Specifications

Sun Pharmaceutical Industries, Inc. NDC 57664-242-88 D-1504-2016
Class III · Low risk Terminated

Methylprednisolone Tablets

Reason Labeling: Incorrect or Missing Lot and/or Exp Date: incorrect expiration date of 02/0218 is printed on the container label instead of the correct expiration date of 02/2018.

Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-003-14 D-0205-2017
Class III · Low risk Terminated

Seconal Sodium

Reason Labeling: Incorrect or Missing Package Insert: Package insert is missing warning regarding anaphylaxis.

Valeant Pharmaceuticals North America LLC D-1059-2016
Class III · Low risk Terminated

Cyproheptadine Hydrochloride Syrup

Reason Subpotency: product assayed and found OOS for cyproheptadine

Lyne Laboratories, Inc. NDC 64980-0504-48 D-1062-2016
Class III · Low risk Terminated

Sirolimus Tablets

Reason Failed impurities/degradation: out of specification result for impurity secorapamycin.

Dr. Reddy's Laboratories, Inc. NDC 55111-653-01 D-1063-2016
Class III · Low risk Terminated

Urea

Reason Crystallization; complaints received by the manufacturer of crystals forming in product

Exact-Rx Inc NDC 42808-0200-05 D-1465-2016
Class III · Low risk Terminated

Ciprofloxacin OPTH 0.3% SOL

Reason Failed Impurities/Degradation Specifications: Out of specification results for unknown impurity.

Aidarex Pharmaceuticals LLC D-1061-2016
Class III · Low risk Terminated

CEFTRIAXONE for Injection USP

Reason CGMP Deviations: Out of specification (OOS) intermediate in the subsequent processes to manufacture the final API.

Aidarex Pharmaceuticals LLC NDC 53217-0117-01 D-0974-2016
Class III · Low risk Terminated

mitoXANTRONE Injection USP

Reason Failed Impurities/Degradation Specifications: High out of specification results for Impurity D.

Teva North America NDC 0703-4685-01 D-1451-2016
Class III · Low risk Terminated

Irbesartan and Hydrochlorothiazide Tablets

Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect lot number, 327B160012, appears on the case label, the correct lot number, 327B16002 appears on the immediate container.

Prinston Pharmaceutical Inc NDC 43547-331-09 D-1049-2016